Kenvue (US:KVUE) ZACKSยท2025-05-05 14:21Core Insights - Analysts project Kenvue (KVUE) will report quarterly earnings of $0.22 per share, a decline of 21.4% year over year, with revenues expected to reach $3.68 billion, down 5.5% from the same quarter last year [1] Earnings Estimates - Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, indicating a collective reconsideration by covering analysts [2] - Revisions to earnings estimates are significant indicators for predicting potential investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3] Key Metrics Projections - Analysts estimate 'Net Sales- Self Care' at $1.61 billion, reflecting a change of -5.1% from the year-ago quarter [5] - 'Net Sales- Essential Health' is projected to be $1.07 billion, indicating a year-over-year change of -6.2% [5] - 'Net Sales- Skin Health and Beauty' is expected to reach $980.93 million, showing a change of -6.9% from the prior-year quarter [5] Adjusted Operating Income Estimates - 'Adjusted Operating Income- Self Care' is forecasted to be $557.79 million, down from $606 million in the same quarter last year [6] - 'Adjusted Operating Income- Essential Health' is expected to be $89.22 million, a significant decrease from $256 million reported in the same quarter of the previous year [6] - 'Adjusted Operating Income- Skin Health and Beauty' is anticipated to come in at $121.28 million, compared to $149 million in the same quarter last year [7] Stock Performance - Kenvue shares have shown a return of +7.4% over the past month, outperforming the Zacks S&P 500 composite's +0.4% change, with a Zacks Rank 3 (Hold) indicating expected performance in line with the overall market [7]